InvestorsHub Logo
Followers 13
Posts 724
Boards Moderated 0
Alias Born 11/17/2011

Re: None

Sunday, 10/21/2012 4:36:35 PM

Sunday, October 21, 2012 4:36:35 PM

Post# of 403036
What would the potential benefit toward DF/BI be if a PR were to go out about p21 success? Any of you analysts out there have a grasp on that? I imagine if the benefit is there, the PR will be there. If there is no benefit, or such a PR about the early success would cause disruptions to the study, then I wouldn't expect to see an early PR. I guess I can see it both ways - interest/money flows into the institutions, or too much early publicity creating too much hype at risk could be destructive to DF/BI reputation (should p21 exist but for some reason tumors don't shrink). I hate to say it, but business do not like to boast products before total confirmation, just not wise from a business sense. Hope I'm wrong, I would love to see an early PR on p21, but I won't blame them for waiting till tumor shrink occurs. That still leaves plenty of PR's to provide, just not detailed study result PR's.

I'm with you Drano - loaded to the tippy top and a calm 'don't worry, be happy' aftertaste on each refreshing sip/gulp of guinness.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News